Daniel D. Christensen

417 total citations
21 papers, 315 citations indexed

About

Daniel D. Christensen is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology. According to data from OpenAlex, Daniel D. Christensen has authored 21 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 6 papers in Physiology and 5 papers in Pharmacology. Recurrent topics in Daniel D. Christensen's work include Dementia and Cognitive Impairment Research (7 papers), Alzheimer's disease research and treatments (6 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Daniel D. Christensen is often cited by papers focused on Dementia and Cognitive Impairment Research (7 papers), Alzheimer's disease research and treatments (6 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Daniel D. Christensen collaborates with scholars based in United States, Canada and United Kingdom. Daniel D. Christensen's co-authors include Darold A. Treffert, Jeffrey L. Cummings, Marwan N. Sabbagh, Martin R. Farlow, David Geldmacher, P. Betz, Debra Cherry, Lauri V. Laitinen, Bruce L. Miller and Marwan Hariz and has published in prestigious journals such as Scientific American, Alzheimer s & Dementia and BMC Geriatrics.

In The Last Decade

Daniel D. Christensen

20 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel D. Christensen United States 13 94 89 84 58 41 21 315
Luisa Bartorelli Italy 10 172 1.8× 75 0.8× 76 0.9× 37 0.6× 46 1.1× 18 387
Miquel Baquero Spain 9 91 1.0× 78 0.9× 151 1.8× 36 0.6× 54 1.3× 17 362
C. Revnic Romania 3 130 1.4× 50 0.6× 129 1.5× 37 0.6× 37 0.9× 12 362
Jeff Sevigny United States 6 129 1.4× 107 1.2× 191 2.3× 65 1.1× 45 1.1× 11 355
H. Gerbaldo Germany 10 152 1.6× 57 0.6× 146 1.7× 47 0.8× 50 1.2× 21 407
Kazuto Oya Japan 11 205 2.2× 106 1.2× 83 1.0× 45 0.8× 47 1.1× 15 462
Lon S. Schneider United States 7 117 1.2× 149 1.7× 41 0.5× 30 0.5× 17 0.4× 7 571
J.-J. Péré France 8 238 2.5× 164 1.8× 78 0.9× 30 0.5× 41 1.0× 12 439
Marcos Vasconcelos Pais Brazil 7 114 1.2× 38 0.4× 122 1.5× 30 0.5× 52 1.3× 16 280
Harish Kavirajan United States 8 157 1.7× 89 1.0× 73 0.9× 39 0.7× 167 4.1× 8 496

Countries citing papers authored by Daniel D. Christensen

Since Specialization
Citations

This map shows the geographic impact of Daniel D. Christensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel D. Christensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel D. Christensen more than expected).

Fields of papers citing papers by Daniel D. Christensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel D. Christensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel D. Christensen. The network helps show where Daniel D. Christensen may publish in the future.

Co-authorship network of co-authors of Daniel D. Christensen

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel D. Christensen. A scholar is included among the top collaborators of Daniel D. Christensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel D. Christensen. Daniel D. Christensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cummings, Jeffrey L., David Geldmacher, Martin R. Farlow, et al.. (2013). High‐Dose Donepezil (23 mg/day) for the Treatment of Moderate and Severe Alzheimer's Disease: Drug Profile and Clinical Guidelines. CNS Neuroscience & Therapeutics. 19(5). 294–301. 50 indexed citations
2.
Sabbagh, Marwan N., Daniel D. Christensen, Rachelle S. Doody, et al.. (2013). Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer’s disease: analysis of effects of baseline features on treatment response. BMC Geriatrics. 13(1). 56–56. 22 indexed citations
3.
Ferris, Steven H., Jeffrey L. Cummings, Daniel D. Christensen, et al.. (2013). Effects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer's disease: evaluating the impact of baseline severity. Alzheimer s Research & Therapy. 5(1). 12–12. 12 indexed citations
4.
Christensen, Daniel D.. (2012). Higher-Dose (23 mg/day) Donepezil Formulation for the Treatment of Patients with Moderate-to-Severe Alzheimer's Disease. Postgraduate Medicine. 124(6). 110–116. 14 indexed citations
5.
Grossberg, George T., et al.. (2010). The Art of Sharing the Diagnosis and Management of Alzheimer’s Disease With Patients and Caregivers. The Primary Care Companion to The Journal of Clinical Psychiatry. 12(1). PCC.09cs00833–PCC.09cs00833. 25 indexed citations
6.
Zubrick, Stephen R., Catherine Taylor, David Lawrence, et al.. (2009). Round Table : Lifecourse Epidemiology : The development of human capability across the lifecourse: Perspectives from childhood. eSpace (Curtin University). 16(3). 6–10. 2 indexed citations
7.
Zubrick, Stephen R., Catherine L. Taylor, David Lawrence, et al.. (2009). The Development of Human Capability across the Lifecourse: Perspectives from Childhood. UWA Profiles and Research Repository (University of Western Australia). 16(3). 6–10. 17 indexed citations
8.
Cummings, Jeffrey L., et al.. (2008). CNS volume 13 Supplement 2 Cover and Front matter. CNS Spectrums. 13(S2). f1–f3. 1 indexed citations
9.
Cummings, Jeffrey L., Bruce L. Miller, Daniel D. Christensen, & Debra Cherry. (2008). Creativity and dementia: emerging diagnostic and treatment methods for Alzheimer's disease.. PubMed. 13(2 Suppl 2). 1–20; quiz 22. 21 indexed citations
10.
Christensen, Daniel D.. (2008). Alzheimer's Disease Research: Progress and Promises. CNS Spectrums. 13(S2). 10–14. 1 indexed citations
11.
Christensen, Daniel D.. (2007). Changing the Course of Alzheimer's Disease. The Primary Care Companion to The Journal of Clinical Psychiatry. 9(1). 32–41. 26 indexed citations
12.
Christensen, Daniel D.. (2007). Alzheimer's Disease:Progress in the Development of Anti-amyloid Disease-Modifying Therapies. CNS Spectrums. 12(2). 113–123. 22 indexed citations
13.
Christensen, Daniel D. & Peter Lin. (2007). Practical treatment strategies for patients with Alzheimer's disease.. PubMed. 56(12 Suppl New). S17–23. 7 indexed citations
14.
15.
Treffert, Darold A. & Daniel D. Christensen. (2006). Inside the Mind of a Savant. Scientific American Mind. 17(3). 52–55. 16 indexed citations
16.
Treffert, Darold A. & Daniel D. Christensen. (2005). Inside the Mind of a Savant. Scientific American. 293(6). 108–113. 33 indexed citations
17.
Christensen, Daniel D., et al.. (2002). Anterior Capsulotomy for Treatment of Refractory Obsessive-Compulsive Disorder: Results in a Young and an Old Patient. Stereotactic and Functional Neurosurgery. 79(3-4). 234–244. 18 indexed citations
18.
Christensen, Daniel D.. (2002). Practical Principles for the Management of Alzheimer's Disease. The Primary Care Companion For CNS Disorders. 4(2). 63–69. 1 indexed citations
19.
Christensen, Daniel D., et al.. (1987). Case studies in psychiatry for the house officer. Medical Entomology and Zoology. 1 indexed citations
20.
Williams, Dylan M., et al.. (1974). Serum azide-resistant ferroxidase activity. Biochimica et Biophysica Acta (BBA) - Enzymology. 350(1). 129–134. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luisa Bartorelli Breakdown of academic impact, for papers by Miquel Baquero Breakdown of academic impact, for papers by C. Revnic Breakdown of academic impact, for papers by Jeff Sevigny Breakdown of academic impact, for papers by H. Gerbaldo Breakdown of academic impact, for papers by Kazuto Oya Breakdown of academic impact, for papers by Lon S. Schneider Breakdown of academic impact, for papers by J.-J. Péré Breakdown of academic impact, for papers by Marcos Vasconcelos Pais Breakdown of academic impact, for papers by Harish Kavirajan
Rankless by CCL
2026